Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, PA, USA.
Professor, Acibadem University and Co-founder, International Joint Center, Istanbul, Turkey.
Clin Orthop Relat Res. 2024 Sep 1;482(9):1614-1623. doi: 10.1097/CORR.0000000000002944. Epub 2024 Jan 3.
The severity of degenerative changes of the hip is known to adversely impact the outcomes of the treatment of femoroacetabular impingement (FAI). Although the operative indications for FAI have expanded to include patients with moderate degrees of hip osteoarthritis, the exact stage of hip osteoarthritis at which surgery for FAI can offer clinical benefits is still uncertain.
QUESTIONS/PURPOSES: (1) How does the survivorship free from conversion to THA and survivorship free from revision differ between patients with preexisting Tönnis Grades 2 or 3 changes and those without advanced degenerative changes (Tönnis Grade 0 or 1) after mini-open femoroacetabular osteoplasty? (2) What are the differences in hip-specific and general health outcome scores between the two groups after mini-open femoroacetabular osteoplasty?
From December 2003 to April 2019, we treated 901 patients for FAI, and their clinical data were systematically recorded in a longitudinally maintained database. Mini-open femoroacetabular osteoplasty was our preferred surgical approach because of the surgeon's extensive experience with the technique. Among the entire dataset, 6% of patients (51 individuals) had Tönnis Grade 2 or higher hip osteoarthritis, while the remaining 94% (850 patients) had no or mild degenerative changes (Tönnis Grade 0 or 1). In the Tönnis Grade 2 or 3 group, three patients were lost before the minimum 2-year follow-up duration, leaving 4% (48 patients) who qualified for inclusion in the study. For the matched group with Tönnis Grade 0 or 1, 5% (45 patients) were excluded because of incomplete data, and a further 7% (58 patients) were excluded because they did not have 2 years of follow-up, leaving 83% (747 patients) who were eligible for the matching process. Matching was based on patient age (within 1 year), gender, and BMI (within one unit). Matching resulted in the inclusion of 144 randomly selected control patients in this retrospective, comparative study. General indications for femoroacetabular osteoplasty included symptoms of pain and restricted hip motion in young, active patients with signs of FAI evident on physical examination and radiographs. Patient demographics, medical history, radiographic parameters, and intraoperative findings were compared between the two groups to establish baseline differences and identify potential confounding variables. There was no difference in the mean ± standard deviation age between the cohort of interest and control group (39 ± 10 years and 38 ± 11 years, respectively; p = 0.67). There was no difference in the mean follow-up duration (7 ± 3 years versus 8 ± 2 years; p = 0.25) or the preoperative symptomatic period between the study and control groups (2 ± 2 years versus 3 ± 6 years; p = 0.09). There was no difference in the prevalence of dysplasia, slipped capital femoral epiphysis, Perthes disease, or avascular necrosis of the hip between the two groups. Intraoperatively, the groups did not differ in terms of labral repair (65% [31 of 48] versus 78% [113 of 144]; p = 0.08) and labral transplantation (2%; p > 0.99 for both); however, labral resection was performed more frequently in the study group (63% [30 of 48] versus 42% [60 of 144]; p = 0.002). At a minimum of 2 years of follow-up, survivorship free from conversion to THA and survivorship free from revision surgeries, as well as the latest clinical and functional outcome scores (SF-36, Hip Disability and Osteoarthritis Outcome Score, and modified Harris hip score), were compared between groups.
Survivorship free from conversion to THA at 5 years was lower among patients with preexisting Tönnis Grades 2 or 3 changes than it was among patients matched for age, gender, and BMI who did not have advanced degenerative changes (Tönnis Grade 0 or 1) after mini-open femoroacetabular osteoplasty (75% [95% confidence interval 64% to 88%] versus 92% [95% CI 87% to 96%]; p < 0.001). No patients in either group underwent reoperation other than conversion to THA. Although the groups did not differ at baseline in terms of their outcomes scores, the group with more visible arthritis had lower postoperative Hip Disability and Osteoarthritis Outcome Scores than the control group (60 ± 21 points versus 86 ± 11 points, mean difference 26 points [95% CI 10 to 41]; p =0.004). There were no other between-group differences in outcome scores after surgery.
In our study, approximately 25% of patients undergoing mini-open femoroacetabular osteoplasty with Tönnis Grade 2 or higher osteoarthritis underwent conversion to THA within 5 years. Some postoperative functional scores were lower in patients with advanced arthritis than in matched patients with no or mild arthritis. We emphasize the importance of exercising caution when considering femoroacetabular osteoplasty in patients in whom advanced arthritis is already evident at the time of presentation.
Level III, therapeutic study.
髋关节退行性改变的严重程度已知会对股骨髋臼撞击症(FAI)治疗的结果产生不利影响。虽然 FAI 的手术适应证已经扩大到包括中度髋关节骨关节炎患者,但 FA I 手术可以提供临床益处的确切髋关节骨关节炎阶段仍不确定。
问题/目的:(1)在 mini-open 股骨髋臼成形术(mini-open femoroacetabular osteoplasty)后,与没有进展性退行性改变(Tönnis 分级 0 或 1)的患者相比,预先存在 Tönnis 分级 2 或 3 改变的患者的免于转换为全髋关节置换术(THA)的生存率和免于翻修手术的生存率是否不同?(2)在 mini-open 股骨髋臼成形术后,两组患者的髋关节特异性和总体健康状况评分有何不同?
2003 年 12 月至 2019 年 4 月,我们治疗了 901 例 FAI 患者,其临床数据被系统地记录在一个纵向维护的数据库中。由于医生在该技术方面的丰富经验,我们首选 mini-open 股骨髋臼成形术作为治疗方法。在整个数据集,6%的患者(51 人)有 Tönnis 分级 2 或更高的髋关节骨关节炎,而其余 94%(850 人)没有或只有轻度退行性改变(Tönnis 分级 0 或 1)。在 Tönnis 分级 2 或 3 组中,有 3 名患者在随访 2 年之前失访,留下 4%(48 名)符合纳入标准的患者。对于 Tönnis 分级 0 或 1 的匹配组,由于数据不完整,有 5%(45 名)被排除,另有 7%(58 名)没有 2 年随访,留下 83%(747 名)符合匹配过程的患者。匹配是基于患者年龄(1 年内)、性别和 BMI(1 个单位内)。匹配纳入了 144 名随机选择的对照组患者进行回顾性、比较研究。股骨髋臼成形术的一般适应证包括疼痛和髋关节运动受限的年轻、活跃患者,这些患者在体格检查和影像学检查中显示出 FAI 的迹象。比较两组患者的人口统计学数据、病史、影像学参数和术中发现,以确定基线差异和识别潜在的混杂变量。研究组和对照组的平均年龄(39 ± 10 岁和 38 ± 11 岁)差异无统计学意义(p = 0.67)。平均随访时间(7 ± 3 年和 8 ± 2 年)差异无统计学意义(p = 0.25),研究组和对照组术前症状持续时间(2 ± 2 年和 3 ± 6 年)差异也无统计学意义(p = 0.09)。两组患者的发育不良、股骨头滑脱、佩特兹病或股骨头坏死的患病率无差异。术中,两组在盂唇修复(65%[31/48]与 78%[113/144];p = 0.08)和盂唇移植(2%;p > 0.99)方面无差异;然而,研究组更常进行盂唇切除术(63%[30/48]与 42%[60/144];p = 0.002)。在至少 2 年的随访后,研究组和对照组的免于转换为 THA 的生存率、免于翻修手术的生存率以及最新的临床和功能结局评分(SF-36、髋关节残疾和骨关节炎结局评分以及改良 Harris 髋关节评分)进行了比较。
在 5 年时,与年龄、性别和 BMI 相匹配且没有进展性退行性改变(Tönnis 分级 0 或 1)的患者相比,预先存在 Tönnis 分级 2 或 3 改变的患者免于转换为 THA 的生存率较低(75%[95%置信区间 64%至 88%]与 92%[95%CI 87%至 96%];p < 0.001)。两组均无患者接受除转换为 THA 以外的翻修手术。尽管两组在基线时的结局评分无差异,但关节炎程度更明显的组术后髋关节残疾和骨关节炎结局评分低于对照组(60 ± 21 分与 86 ± 11 分,平均差值 26 分[95%CI 10 至 41];p =0.004)。手术后两组之间在其他结局评分方面没有差异。
在我们的研究中,大约 25%的接受 Tönnis 分级 2 或更高的骨关节炎的 mini-open 股骨髋臼成形术患者在 5 年内转换为 THA。一些术后功能评分在关节炎程度较重的患者中低于关节炎程度较轻的匹配患者。我们强调,在考虑 FA I 手术时,如果患者在就诊时已经存在晚期关节炎,应谨慎行事。
III 级,治疗性研究。